Norcantharidin, derivative of cantharidin, for cancer stem cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Hsieh, Chen Hsi ^a,b   Chao, K S Clifford ^c   Liao, Hui Fen ^b,d   Chen, Yu Jen ^b,e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Columbia University ^*  (United States)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA CATENIN; CANTHARIDIN; NORCANTHARIDIN; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

ANGIOGENESIS; ARTICLE; BEETLE; CANCER INHIBITION; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CELL RENEWAL; CHEMOPROPHYLAXIS; DRUG TRANSPORT; HUMAN; METASTASIS; MULTIDRUG RESISTANCE; MYLABRIS PHALERATA; PRIORITY JOURNAL; TUMOR INVASION;

EID: 84885348916     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/838651     Document Type: Article

References (130)

1. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997 3 7 730 737 2-s2.0-0030789242 10.1038/nm0797-730 (Pubitemid 27298715)
2. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors. Cancer Research 2003 63 18 5821 5828 2-s2.0-0141842674 (Pubitemid 37187480)
3. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
4. + cancer stem cells in human liver cancer. Cancer Cell 2008 13 2 153 166 2-s2.0-38549139140 10.1016/j.ccr.2008.01.013 (Pubitemid 351163165)
5. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007 445 7123 106 110 2-s2.0-33846100356 10.1038/nature05372 (Pubitemid 46067310)
6. Korkaya H., Paulson A., Charafe-Jauffret E., Ginestier C., Brown M., Dutcher J., Clouthier S. G., Wicha M. S., Regulation of mammary stem/progenitor cells by PTEN/Akt/ β -catenin signaling. PLoS Biology 2009 7 6 2-s2.0-67649969473 10.1371/journal.pbio.1000121 e1000121
7. Isakoff S. J., Triple-negative breast cancer: role of specific chemotherapy agents. Cancer Journal 2010 16 1 53 61 2-s2.0-77149138342 10.1097/PPO.0b013e3181d24ff7
8. Subramaniam D., Ramalingam S., Houchen C. W., Anant S., Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Reviews in Medicinal Chemistry 2010 10 5 359 371 2-s2.0-77955872105
9. Chang W.-W., Chien H. L., Lee P., Lin J., Hsu C.-W., Hung J.-T., Lin J.-J., Yu J.-C., Shao L.-E., Yu J., Wong C.-H., Yu A. L., Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 33 11667 11672 2-s2.0-50149118358 10.1073/pnas.0804979105
10. Hwang-Verslues W. W., Kuo W.-H., Chang P.-H., Pan C.-C., Wang H.-H., Tsai S.-T., Jeng Y.-M., Shew J.-Y., Kung J. T., Chen C.-H., Lee E. Y.-H. P., Chang K.-J., Lee W.-H., Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PloS one 2009 4 12 e8377 2-s2.0-77949514174
11. Hambardzumyan D., Squartro M., Holland E. C., Radiation resistance and stem-like cells in brain tumors. Cancer Cell 2006 10 6 454 456 2-s2.0-33845226457 10.1016/j.ccr.2006.11.008 (Pubitemid 44854752)
12. Liu S., Dontu G., Mantle I. D., Patel S., Ahn N.-S., Jackson K. W., Suri P., Wicha M. S., Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research 2006 66 12 6063 6071 2-s2.0-33745728170 10.1158/0008-5472.CAN-06-0054
13. Dontu G., Jackson K. W., McNicholas E., Kawamura M. J., Abdallah W. M., Wicha M. S., Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Research 2004 6 6 R605 R615 2-s2.0-18944375734
14. Smalley M. J., Dale T. C., Wnt signalling in mammalian development and cancer. Cancer and Metastasis Reviews 1999 18 2 215 230 2-s2.0-0033392360 10.1023/A:1006369223282 (Pubitemid 30043859)
15. Pogodina V. V., Elizaveta Nilolaevna Levkovich-75th birthday. Acta Virologica 1975 19 6 509 2-s2.0-0016577166
16. Vasconcelos F. C., Cavalcanti G. B. Jr., Silva K. L., de Meis E., Kwee J. K., Rumjanek V. M., Maia R. C., Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice. Leukemia Research 2007 31 4 445 454 2-s2.0-33846683203 10.1016/j.leukres.2006. 07.016 (Pubitemid 46198938)
17. Gottesman M. M., Fojo T., Bates S. E., Multidrug resistance in cancer: role of ATP-dependent transporters. Nature Reviews Cancer 2002 2 1 48 58 2-s2.0-0036364467 (Pubitemid 37328807)
18. Wang G.-S., Medical uses of mylabris in ancient China and recent studies. Journal of Ethnopharmacology 1989 26 2 147 162 2-s2.0-0024428817 (Pubitemid 19257209)
19. Sakoff J. A., Ackland S. P., Baldwin M. L., Keane M. A., McCluskey A., Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Investigational New Drugs 2002 20 1 1 11 2-s2.0-0036208532 10.1023/A:1014460818734 (Pubitemid 34251646)
20. Einbinder J. M., Parshley M. S., Walzer R. A., Sanders S. L., The effect of cantharidin on epithelial cells in tissue culture. Journal of Investigative Dermatology 1969 52 3 291 303 2-s2.0-0014481316
21. McCluskey A., Bowyer M. C., Collins E., Sim A. T. R., Sakoff J. A., Baldwin M. L., Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity. Bioorganic and Medicinal Chemistry Letters 2000 10 15 1687 1690 2-s2.0-0034618205 10.1016/S0960-894X(00)00323-1 (Pubitemid 30495241)
22. Efferth T., Rauh R., Kahl S., Tomicic M., Böchzelt H., Tome M. E., Briehl M. M., Bauer R., Kaina B., Molecular modes of action of cantharidin in tumor cells. Biochemical Pharmacology 2005 69 5 811 818 2-s2.0-13844267553 10.1016/j.bcp.2004.12.003 (Pubitemid 40248623)
23. Karras D. J., Farrell S. E., Harrigan R. A., Henretig F. M., Gealt L., Poisoning from 'spanish fly' (cantharidin). American Journal of Emergency Medicine 1996 14 5 478 483 2-s2.0-0029742794 10.1016/S0735-6757(96)90158-8 (Pubitemid 26272253)
24. Fan Y.-Z., Fu J.-Y., Zhao Z.-M., Chen C.-Q., Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells. World Journal of Gastroenterology 2005 11 16 2431 2437 2-s2.0-18744408486 (Pubitemid 40667977)
25. 2-terminal kinase signaling pathways in human hepatoma HepG2 cells. British Journal of Pharmacology 2003 140 3 461 470 2-s2.0-0142184964 10.1038/sj.bjp.0705461 (Pubitemid 37330490)
26. Yang P.-Y., Chen M.-F., Kao Y.-H., Hu D.-N., Chang F.-R., Wu Y.-C., Norcantharidin induces apoptosis of breast cancer cells: involvement of activities of mitogen activated protein kinases and signal transducers and activators of transcription. Toxicology in Vitro 2011 25 3 699 707 2-s2.0-79952043014 10.1016/j.tiv.2011.01.011
27. Chen Y.-J., Kuo C.-D., Tsai Y.-M., Yu C.-C., Wang G.-S., Liao H.-F., Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells. Anti-Cancer Drugs 2008 19 1 55 64 2-s2.0-36549025029 10.1097/CAD.0b013e3282f18826 (Pubitemid 350190968)
28. Bei Y. Y., Chen X. Y., Liu Y., Xu J. Y., Wang W. J., Gu Z. L., Xing K. L., Zhu A. J., Chen W. L., Shi L. S., Wang Q., Zhang X. N., Zhang Q., Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption. International Journal of Nanomedicine 2012 7 1819 1827 10.2147/IJN.S29958
29. Yi S., Wass J., Vincent P., Iland H., Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro. Leukemia Research 1991 15 10 883 886 2-s2.0-0026095943 10.1016/0145-2126(91)90163-N
30. Dorn D. C., Kou C. A., Png K. J., Moore M. A. S., The effect of cantharidins on leukemic stem cells. International Journal of Cancer 2009 124 9 2186 2199 2-s2.0-63449135103 10.1002/ijc.24157
31. Zhang J., Tang Y., Li S., Liao C., Guo X., Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitro. Journal of Drug Targeting 2010 18 9 675 687 2-s2.0-77957783919 10.3109/10611861003649720
32. Cimmino F., Scoppettuolo M. N., Carotenuto M., De Antonellis P., Dato V. D., De Vita G., Zollo M., Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/ β -catenin signaling. Journal of Neuro-Oncology 2012 106 1 59 70 2-s2.0-83055173058 10.1007/s11060-011-0645-y
33. Chuang K. A., Lieu C. H., Tsai W. J., Wu M. H., Chen Y. C., Liao J. F., Wang C. C., Kuo Y. C., Evaluation of anti-Wnt/ β -catenin signaling agents by pGL4-TOP transfected stable cells with a luciferase reporter system. Brazilian Journal of Medical and Biological Research 2010 43 10 931 941 2-s2.0-78149272917 10.1590/S0100-879X2010007500091
34. Chen Y.-J., Shieh C.-J., Tsai T.-H., Kuo C.-D., Ho L.-T., Liu T.-Y., Liao H.-F., Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT28 colorectal adenocarcinoma cells. Anti-Cancer Drugs 2005 16 3 293 299 2-s2.0-14144249977 10.1097/00001813-200503000-00008 (Pubitemid 40283944)
35. Fan Y.-Z., Zhao Z.-M., Fu J.-Y., Chen C.-Q., Sun W., Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary and Pancreatic Diseases International 2010 9 4 414 422 2-s2.0-77955608840
36. Fan Y.-Z., Fu J.-Y., Zhao Z.-M., Chen C.-Q., Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Hepatobiliary and Pancreatic Diseases International 2007 6 1 72 80 2-s2.0-33846967813 (Pubitemid 46243165)
37. Chen Y.-C., Chang S.-C., Wu M.-H., Chuang K.-A., Wu J.-Y., Tsai W.-J., Kuo Y.-C., Norcantharidin reduced cyclins and cytokines production in human peripheral blood mononuclear cells. Life Sciences 2009 84 7-8 218 226 2-s2.0-58249124759 10.1016/j.lfs.2008.11.020
38. Chen Y.-J., Tsai Y.-M., Kuo C.-D., Ku K.-L., Shie H.-S., Liao H.-F., Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect. Life Sciences 2009 85 17-18 642 651 2-s2.0-70349748544 10.1016/j.lfs.2009.09.003
39. Chen Y. J., Kuo C. D., Chen S. H., Chen W.-J., Huang W.-C., Chao K. S. C., Liao H.-F., Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. PLoS One 2012 7 5 e37006
40. Chen Y.-J., Chang W.-M., Liu Y.-W., Lee C.-Y., Jang Y.-H., Kuo C.-D., Liao H.-F., A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells. Chemico-Biological Interactions 2009 181 3 440 446 2-s2.0-70249142794 10.1016/j.cbi.2009.07.004
41. Huang Y., Liu Q., Liu K., Yagasaki K., Zhang G., Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology 2009 59 3 201 208 2-s2.0-70449530514 10.1007/s10616-009-9210-3
42. Liu Q., Duan H., Luan J., Yagasaki K., Zhang G., Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. Cytotechnology 2009 59 3 211 217 2-s2.0-70449524216 10.1007/s10616-009-9223-y
43. Chen F., Castranova V., Shi X., New insights into the role of nuclear factor- B in cell growth regulation. American Journal of Pathology 2001 159 2 387 397 2-s2.0-0034885358 (Pubitemid 32751067)
44. Yeh C.-B., Hsieh M.-J., Hsieh Y.-H., Chien M.-H., Chiou H.-L., Yang S.-F., Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-Kb activity. PLoS One 2012 7 2 2-s2.0-84856750556 10.1371/journal.pone.0031055 e31055
45. Guan M., Zhu Q. L., Liu Y., Bei Y. Y., Gu Z. L., Zhang X. N., Zhang Q., Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers. International Journal of Nanomedicine 2012 7 1921 1930
46. Kok S.-H., Cheng S.-J., Hong C.-Y., Lee J.-J., Lin S.-K., Kuo Y.-S., Chiang C.-P., Kuo M. Y.-P., Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio. Cancer Letters 2005 217 1 43 52 2-s2.0-10444235120 10.1016/j.canlet.2004. 07.045 (Pubitemid 39642865)
47. Hsieh C.-H., Liao H.-F., Kuo C.-D., Huang Y.-C., Shueng P.-W., Hsu Y.-P., Wang L.-Y., Tsai T.-H., Chen Y.-J., Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival. Transplantation 2011 92 8 848 857 2-s2.0-80054764025 10.1097/TP.0b013e31822d8708
48. Li Y., Sun Y., Liu F., Sun L., Li J., Duan S., Liu H., Peng Y., Xiao L., Liu Y., Xi Y., You Y., Li H., Wang M., Wang S., Hou T., Norcantharidin inhibits renal interstitial fibrosis by blocking the tubular epithelial-mesenchymal transition. PLoS One 2013 8 6 e66356
49. Li Y., Chen Q., Liu F.-Y., Peng Y.-M., Hou T., Duan S.-B., Li J., Luo J.-H., Sun L., Ling G.-H., Norcantharidin attenuates tubulointerstitial fibrosis in rat models with diabetic nephropathy. Renal Failure 2011 33 2 233 241 2-s2.0-79951972078 10.3109/0886022X.2011.553305 553305
50. Yan M. S., Xiue S., Wei L. X., Piao X. H., The preliminary observation on immunosuppressive effect of norcantharidin in mice. Immunopharmacology and Immunotoxicology 1993 15 1 79 85 2-s2.0-0027401133 (Pubitemid 23069481)
51. Turashvili G., Bouchal J., Burkadze G., Kolar Z., Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 2007 73 5 213 223 2-s2.0-33847389710 10.1159/000098207
52. Akiyama T., Wnt/ β -catenin signaling. Cytokine and Growth Factor Reviews 2000 11 4 273 282 2-s2.0-0033830945 10.1016/S1359-6101(00)00011-3
53. Polakis P., Wnt signaling and cancer. Genes and Development 2000 14 15 1837 1851 2-s2.0-0033895709 (Pubitemid 30639518)
54. Nelson W. J., Nusse R., Convergence of Wnt, β -catenin, and cadherin pathways. Science 2004 303 5663 1483 1487 2-s2.0-1542347695 10.1126/science.1094291 (Pubitemid 38314410)
55. He T.-C., Sparks A. B., Rago C., Hermeking H., Zawel L., Da Costa L. T., Morin P. J., Vogelstein B., Kinzler K. W., Identification of c-MYC as a target of the APC pathway. Science 1998 281 5382 1509 1512 2-s2.0-0032483439 10.1126/science.281.5382.1509 (Pubitemid 28425575)
56. Tetsu O., McCormick F., β -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999 398 6726 422 426 2-s2.0-0033119801 10.1038/18884 (Pubitemid 29180374)
57. Mann B., Gelos M., Siedow A., Hanski M. L., Gratchev A., Ilyas M., Bodmer W. F., Moyer M. P., Riecken E. O., Buhr H. J., Hanski C., Target genes of β -catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1603 1608 2-s2.0-13044281685 10.1073/pnas.96.4.1603 (Pubitemid 29098498)
58. Clevers H., Wnt/ β -catenin signaling in development and disease. Cell 2006 127 3 469 480 2-s2.0-33746808398 10.1016/j.cell.2006.10.018 (Pubitemid 44647433)
59. Lin S.-Y., Xia W., Wang J. C., Kwong K. Y., Spohn B., Wen Y., Pestell R. G., Hung M.-C., β -catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America 2000 97 8 4262 4266 2-s2.0-0034636153 10.1073/pnas.060025397 (Pubitemid 30226121)
60. Orsulic S., Huber O., Aberle H., Arnold S., Kemler R., E-cadherin binding prevents β -catenin nuclear localization and β -catenin/LEF-1- mediated transactivation. Journal of Cell Science 1999 112 part 8 1237 1245 2-s2.0-0032891720 (Pubitemid 29218912)
61. Gritli-Linde A., Bei M., Maas R., Zhang X. M., Linde A., McMahon A. P., Shh signaling within the dental epithelium is necessary for cell proliferation, growth and polarization. Development 2002 129 23 5323 5337 2-s2.0-0036914924 10.1242/dev.00100 (Pubitemid 36040329)
62. Yang L., Xie G., Fan Q., Xie J., Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010 29 4 469 481 2-s2.0-75749139262 10.1038/onc.2009.392
63. Liu S., Dontu G., Wicha M. S., Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Research 2005 7 3 86 95 2-s2.0-18944407603 10.1186/bcr1021 (Pubitemid 40704127)
64. Cohen M. M. Jr., The hedgehog signaling network. American Journal of Medical Genetics 2003 123 1 5 28 2-s2.0-0142153787 (Pubitemid 37309353)
65. Lewis M. T., Veltmaat J. M., Next top, the twilight zone: hedgehog network regulation of mammary gland development. Journal of Mammary Gland Biology and Neoplasia 2004 9 2 165 181 2-s2.0-4444327331 10.1023/B:JOMG. 0000037160.24731.35 (Pubitemid 39177501)
66. Feng Y.-Z., Shiozawa T., Miyamoto T., Kashima H., Kurai M., Suzuki A., Ying-Song J., Konishi I., Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells. Clinical Cancer Research 2007 13 5 1389 1398 2-s2.0-33947357165 10.1158/1078-0432.CCR-06- 1407 (Pubitemid 46450427)
67. Di Magliano M. P., Hebrok M., Hedgehog signalling in cancer formation and maintenance. Nature Reviews Cancer 2003 3 12 903 911 2-s2.0-0345059765 (Pubitemid 37500175)
68. Medina V., Calvo M. B., Díaz-Prado S., Espada J., Hedgehog signalling as a target in cancer stem cells. Clinical and Translational Oncology 2009 11 4 199 207 2-s2.0-67650249220 10.1007/s12094-009-0341-y
69. Carpenter R. L., Lo H. W., Hedgehog pathway and GLI1 isoforms in human cancer. Discovery Medicine 2012 13 69 105 113
70. Huelsken J., Birchmeier W., New aspects of Wnt signaling pathways in higher vertebrates. Current Opinion in Genetics and Development 2001 11 5 547 553 2-s2.0-0035479835 10.1016/S0959-437X(00)00231-8 (Pubitemid 32800729)
71. Ingham P. W., McMahon A. P., Hedgehog signaling in animal development: paradigms and principles. Genes and Development 2001 15 23 3059 3087 2-s2.0-0035577854 10.1101/gad.938601 (Pubitemid 33115673)
72. Price M. A., Kalderon D., Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by Glycogen Synthase Kinase 3 and Casein Kinase 1. Cell 2002 108 6 823 835 2-s2.0-0037155737 10.1016/S0092- 8674(02)00664-5 (Pubitemid 34327533)
73. Kalderon D., Similarities between the Hedgehog and Wnt signaling pathways. Trends in Cell Biology 2002 12 11 523 531 2-s2.0-0036849497 10.1016/S0962-8924(02)02388-7 (Pubitemid 35346703)
74. Hoseong Yang S., Andl T., Grachtchouk V., Wang A., Liu J., Syu L.-J., Ferris J., Wang T. S., Glick A. B., Millar S. E., Dlugosz A. A., Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/ β -catenin signaling. Nature Genetics 2008 40 9 1130 1135 2-s2.0-50449084075 10.1038/ng.192
75. Pap M., Cooper G. M., Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. Journal of Biological Chemistry 1998 273 32 19929 19932 2-s2.0-0032493729 10.1074/jbc.273.32.19929 (Pubitemid 28377539)
76. Yost C., Torres M., Miller J. R., Huang E., Kimelman D., Moon R. T., The axis-inducing activity, stability, and subcellular distribution of β -catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes and Development 1996 10 12 1443 1454 2-s2.0-0029683606 (Pubitemid 26260702)
77. Sizemore N., Leung S., Stark G. R., Activation of phosphatidylinositol 3-kinase in response to interleukin- 1 leads to phosphorylation and activation of the NF- B p65/RelA subunit. Molecular and Cellular Biology 1999 19 7 4798 4805 2-s2.0-0033038491 (Pubitemid 29289518)
78. Aggarwal B. B., Nuclear factor- B: the enemy within. Cancer Cell 2004 6 3 203 208 2-s2.0-4544342570 10.1016/j.ccr.2004.09.003 (Pubitemid 39222032)
79. Riobó N. A., Lu K., Ai X., Haines G. M., Emerson C. P. Jr., Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proceedings of the National Academy of Sciences of the United States of America 2006 103 12 4505 4510 2-s2.0-33645220566 10.1073/pnas.0504337103
80. Kenney A. M., Widlund H. R., Rowitch D. H., Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 2004 131 1 217 228 (Pubitemid 38111428)
81. Fu J.-R., Liu W.-L., Zhou J.-F., Sun H.-Y., Xu H.-Z., Luo L., Zhang H., Zhou Y.-F., Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via PI 3-kinase/Akt signaling pathways. Acta Pharmacologica Sinica 2006 27 6 685 693 2-s2.0-33745379407 10.1111/j.1745-7254.2006.00335.x (Pubitemid 43943916)
82. Kanda S., Mochizuki Y., Suematsu T., Miyata Y., Nomata K., Kanetake H., Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. Journal of Biological Chemistry 2003 278 10 8244 8249 2-s2.0-0037424249 10.1074/jbc.M210635200 (Pubitemid 36800569)
83. Hahn H., Wojnowski L., Specht K., Kappler R., Calzada-Wack J., Potter D., Zimmer A., Müller U., Samson E., Quintanilla-Martinez L., Zimmer A., Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. Journal of Biological Chemistry 2000 275 37 28341 28344 2-s2.0-0034665975
84. Rao G., Pedone C. A., Valle L. D., Reiss K., Holland E. C., Fults D. W., Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004 23 36 6156 6162 2-s2.0-4444273153 10.1038/sj.onc.1207818 (Pubitemid 39178868)
85. Yoo Y. A., Kang M. H., Lee H. J., Kim B.-H., Park J. K., Kim H. K., Kim J. S., Oh S. C., Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Research 2011 71 22 7061 7070 2-s2.0-81155126047 10.1158/0008-5472.CAN-11-1338
86. Xia Y.-P., Dai R.-L., Li Y.-N., Mao L., Xue Y.-M., He Q.-W., Huang M., Huang Y., Mei Y.-W., Hu B., The protective effect of sonic hedgehog is mediated by the propidium iodide 3-kinase/AKT/Bcl-2 pathway in cultured rat astrocytes under oxidative stress. Neuroscience 2012 209 1 11 2-s2.0-84859264334 10.1016/j.neuroscience.2012.02.019
87. Nakashima H., Nakamura M., Yamaguchi H., Yamanaka N., Akiyoshi T., Koga K., Yamaguchi K., Tsuneyoshi M., Tanaka M., Katano M., Nuclear factor- B contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Research 2006 66 14 7041 7049 2-s2.0-33746888182 10.1158/0008-5472.CAN-05-4588 (Pubitemid 44197680)
88. Kasperczyk H., Baumann B., Debatin K.-M., Fulda S., Characterization of sonic hedgehog as a novel NF- B target gene that promotes NF- B-mediated apoptosis resistance and tumor growth in vivo. The FASEB Journal 2009 23 1 21 33 2-s2.0-58249124375 10.1096/fj.08-111096
89. Wang Z., Li Y., Banerjee S., Sarkar F. H., Emerging role of Notch in stem cells and cancer. Cancer Letters 2009 279 1 8 12 2-s2.0-67349193226 10.1016/j.canlet.2008.09.030
90. Wilson A., Radtke F., Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Letters 2006 580 12 2860 2868 2-s2.0-33646551228 10.1016/j.febslet.2006.03.024 (Pubitemid 43729170)
91. Peacock C. D., Watkins D. N., Cancer stem cells and the ontogeny of lung cancer. Journal of Clinical Oncology 2008 26 17 2883 2889 2-s2.0-45549097925 10.1200/JCO.2007.15.2702
92. Fan X., Eberhart C. G., Medulloblastoma stem cells. Journal of Clinical Oncology 2008 26 17 2821 2827 2-s2.0-45549091581 10.1200/JCO.2007.15.2264
93. Kakarala M., Wicha M. S., Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. Journal of Clinical Oncology 2008 26 17 2813 2820 2-s2.0-45549103691 10.1200/JCO.2008.16.3931
94. Scoville D. H., Sato T., He X. C., Li L., Current view: intestinal stem cells and signaling. Gastroenterology 2008 134 3 849 864 2-s2.0-39749092525 10.1053/j.gastro.2008.01.079 (Pubitemid 351312767)
95. Oswald F., Liptay S., Adler G., Schmid R. M., NF- B2 is a putative target gene of activated Notch-1 via RBP-J Molecular and Cellular Biology 1998 18 4 2077 2088 2-s2.0-0031594575 (Pubitemid 28152657)
96. Jang M.-S., Miao H., Carlesso N., Shelly L., Zlobin A., Darack N., Qin J.-Z., Nickoloff B. J., Miele L., Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. Journal of Cellular Physiology 2004 199 3 418 433 2-s2.0-2342471446 10.1002/jcp.10467 (Pubitemid 38580438)
97. Wang Z., Banerjee S., Li Y., Rahman K. M. W., Zhang Y., Sarkar F. H., Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear factor- B, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Research 2006 66 5 2778 2784 2-s2.0-33645049305 10.1158/0008-5472.CAN-05-4281
98. Cheng P., Zlobin A., Volgina V., Gottipati S., Osborne B., Simel E. J., Miele L., Gabrilovichz D. I., Notch-1 regulates NF- B activity in hemopoietic progenitor cells. Journal of Immunology 2001 167 8 4458 4467 2-s2.0-0035887655 (Pubitemid 32954323)
99. Huang C.-Y., Fong Y.-C., Lee C.-Y., Chen M.-Y., Tsai H.-C., Hsu H.-C., Tang C.-H., CCL5 increases lung cancer migration via PI3K, Akt and NF- B pathways. Biochemical Pharmacology 2009 77 5 794 803 2-s2.0-59749090797 10.1016/j.bcp.2008.11.014
100. Wei Y.-Y., Chen Y.-J., Hsiao Y.-C., Huang Y.-C., Lai T.-H., Tang C.-H., Osteoblasts-derived TGF- β 1 enhance motility and integrin upregulation through Akt, ERK, and NF- B-dependent pathway in human breast cancer cells. Molecular Carcinogenesis 2008 47 7 526 537 2-s2.0-45949095352 10.1002/mc.20411 (Pubitemid 351898583)
101. Patel N. H., Rothenberg M. L., Multidrug resistance in cancer chemotherapy. Investigational New Drugs 1994 12 1 1 13 2-s2.0-0028308901 10.1007/BF00873229 (Pubitemid 24209059)
102. Ambudkar S. V., Kimchi-Sarfaty C., Sauna Z. E., Gottesman M. M., P-glycoprotein: from genomics to mechanism. Oncogene 2003 22 47 7468 7485 2-s2.0-0344825356 10.1038/sj.onc.1206948 (Pubitemid 37487170)
103. Marie J.-P., Zhou D.-C., Gurbuxani S., Legrand O., Zittoun R., MDR1/P-glycoprotein in haematological neoplasms. European Journal of Cancer 1996 32 6 1034 1038 2-s2.0-0029894447 10.1016/0959-8049(96)00055-X
104. Cole S. P. C., Bhardwaj G., Gerlach J. H., Mackie J. E., Grant C. E., Almquist K. C., Stewart A. J., Kurz E. U., Duncan A. M. V., Deeley R. G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992 258 5088 1650 1654 2-s2.0-0027095653 (Pubitemid 23012438)
105. Kruh G. D., Belinsky M. G., The MRP family of drug efflux pumps. Oncogene 2003 22 47 7537 7552 2-s2.0-0345724724 10.1038/sj.onc.1206953 (Pubitemid 37487175)
106. Kitazono M., Sumizawa T., Takebayashi Y., Chen Z.-S., Furukawa T., Nagayama S., Tani A., Takao S., Aikou T., Akiyama S.-I., Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. Journal of the National Cancer Institute 1999 91 19 1647 1653 2-s2.0-0033530286 (Pubitemid 29479932)
107. Scheper R. J., Broxterman H. J., Scheffer G. L., Kaaijk P., Dalton W. S., Van Heijningen T. H. M., Van Kalken C. K., Slovak M. L., De Vries E. G. E., Van der Valk P., Meijer C. J. L. M., Pinedo H. M., Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Research 1993 53 7 1475 1479 2-s2.0-0027466646 (Pubitemid 23113213)
108. Legrand O., Simonin G., Beauchamp-Nicoud A., Zittoun R., Marie J.-P., Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood 1999 94 3 1046 1056 2-s2.0-0033179207 (Pubitemid 29361837)
109. Austin Doyle L., Yang W., Abruzzo L. V., Krogmann T., Gao Y., Rishi A. K., Ross D. D., A multidrug resistance transporter from human MCF-7 breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15665 15670 2-s2.0-13044249156 10.1073/pnas.95.26. 15665 (Pubitemid 29018757)
110. Miyake K., Mickley L., Litman T., Zhan Z., Robey R., Cristensen B., Brangi M., Greenberger L., Dean M., Fojo T., Bates S. E., Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Research 1999 59 1 8 13 2-s2.0-0032895533 (Pubitemid 29062946)
111. Doyle L. A., Ross D. D., Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003 22 47 7340 7358 2-s2.0-0345688604 10.1038/sj.onc.1206938 (Pubitemid 37487163)
112. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B., Identification of human brain tumour initiating cells. Nature 2004 432 7015 396 401 2-s2.0-9244241576 10.1038/nature03128 (Pubitemid 39551674)
113. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R., Identification and expansion of human colon-cancer-initiating cells. Nature 2007 445 7123 111 115 2-s2.0-33846095137 10.1038/nature05384 (Pubitemid 46067311)
114. Reya T., Morrison S. J., Clarke M. F., Weissman I. L., Stem cells, cancer, and cancer stem cells. Nature 2001 414 6859 105 111 2-s2.0-0035499267 10.1038/35102167 (Pubitemid 33041634)
115. Sanchez P., Hernández A. M., Stecca B., Kahler A. J., DeGueme A. M., Barrett A., Beyna M., Datta M. W., Datta S., Ruiz I Altaba A., Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proceedings of the National Academy of Sciences of the United States of America 2004 101 34 12561 12566 2-s2.0-4344659678 10.1073/pnas.0404956101 (Pubitemid 39122063)
116. Beachy P. A., Karhadkar S. S., Berman D. M., Tissue repair and stem cell renewal in carcinogenesis. Nature 2004 432 7015 324 331 2-s2.0-9244221172 10.1038/nature03100 (Pubitemid 39551660)
117. Taş S., Avci O., Induction of the differentiation and apoptosis of tumor cells in vivo with efficiency and selectivity. European Journal of Dermatology 2004 14 2 96 102 2-s2.0-1942473030 (Pubitemid 38510025)
118. Molckovsky A., Siu L. L., First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting. Journal of Hematology & Oncology 2008 1 20 2-s2.0-62549160588
119. Wodarz A., Nusse R., Mechanisms of Wnt signaling in development. Annual Review of Cell and Developmental Biology 1998 14 59 88 2-s2.0-0032406715 10.1146/annurev.cellbio.14.1.59 (Pubitemid 29001449)
120. Morin P. J., beta-catenin signaling and cancer. Bioessays 1999 21 12 1021 1030
121. Moon R. T., Bowerman B., Boutros M., Perrimon N., The promise and perils of Wnt signaling through β -catenin. Science 2002 296 5573 1644 1646 2-s2.0-0037205007 10.1126/science.1071549 (Pubitemid 34579151)
122. Emami K. H., Nguyen C., Ma H., Kim D. H., Jeong K. W., Eguchi M., Moon R. T., Teo J. L., Kim H. Y., Moon S. H., Ha J. R., Kahn M., A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. Proceedings of the National Academy of Sciences of the United States of America 2004 101 34 12682 12687 (Pubitemid 39122083)
123. Lepourcelet M., Chen Y.-N. P., France D. S., Wang H., Crews P., Petersen F., Bruseo C., Wood A. W., Shivdasani R. A., Small-molecule antagonists of the oncogenic Tcf/ β -catenin protein complex. Cancer Cell 2004 5 1 91 102 2-s2.0-1642512639 10.1016/S1535-6108(03)00334-9 (Pubitemid 38121599)
124. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
125. Adams G. P., Weiner L. M., Monoclonal antibody therapy of cancer. Nature Biotechnology 2005 23 9 1147 1157 2-s2.0-27144449009 10.1038/nbt1137 (Pubitemid 41486396)
126. Zhou B.-B. S., Zhang H., Damelin M., Geles K. G., Grindley J. C., Dirks P. B., Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nature Reviews Drug Discovery 2009 8 10 806 823 2-s2.0-70349638289 10.1038/nrd2137
127. Burges A., Wimberger P., Kümper C., Gorbounova V., Sommer H., Schmalfeldt B., Pfisterer J., Lichinitser M., Makhson A., Moiseyenko V., Lahr A., Schulze E., Jäger M., Ströhlein M. A., Heiss M. M., Gottwald T., Lindhofer H., Kimmig R., Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study. Clinical Cancer Research 2007 13 13 3899 3905 2-s2.0-34447132202 10.1158/1078-0432.CCR-06-2769 (Pubitemid 47037597)
128. Wang Y. F., Chang C. J., Lin C. P., Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinoma. Head Neck 2012 34 11 1556 1561
129. Sinclair W. K., Morton R. A., X-Ray and ultraviolet sensitivity of synchronized Chinese hamster cells at various stages of the cell cycle. Biophysical Journal 1965 5 1 25
130. Sinclair W. K., Morton R. A., X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiation Research 1966 29 3 450 474 2-s2.0-0013973616